口服卡培他滨联合三维适形放疗在胰腺癌治疗中的应用效果分析  

The Effect of Oral Administration Capecitabine and 3-Dimensional Conformal Radiotherapy on Patients with Pancreatic Carcinoma

作　　者：杨曙[1] 莫凯岚[1] 赖德星[1] 张飞燕[1] 

机构地区：[1]广东药学院附属第一医院放疗科,广东广州510080

出　　处：《临床医学工程》2011年第8期1212-1213,共2页Clinical Medicine & Engineering

摘　　要：目的探讨口服卡培他滨联合三维适形放疗在治疗胰腺癌患者的临床应用效果。方法选择2006年1月～2010年12月收治于我院的42例胰腺癌患者,分为研究组和对照组进行研究,研究组患者采用口服卡培他滨联合三维适形放疗进行治疗,对照组仅使用三维适形放疗进行治疗,然后观察并比较两组患者的临床应用效果。结果经过治疗,观察组的总有效率为57.14%,对照组的总有效率为38.09%。结论胰腺癌患者经口服卡培他滨联合三维适形放疗治疗后,其临床疗效较好且无严重副反应,值得临床推广应用。Objective To evaluate the effect of oral administration capecitabine and 3-dimensional conformal radiotherapy on patients with pancreatic carcinoma.Methods 42 cases with pancreatic carcinoma in our hospital from January 2006 to December 2010 were divided into observation group and control group.Patients in the observation group were treated by oral administration capecitabine and 3-dimensional conformal radiotherapy,patients in the control group were only treated by 3-dimensional conformal radiotherapy,to observe and compare the clinical effects of the two groups.Results After treatment,the total effective rate of the observation group was 57.14%,higher than 38.09% of the control group.Conclusion Oral administration capecitabine and 3-dimensional conformal radiotherapy in treatment of patients with pancreatic carcinoma has high efficacy and few side effects,which is worthy of clinical application.

关 键 词：卡培他滨 三维适形放疗 胰腺癌 

分 类 号：R735.9[医药卫生—肿瘤]